William Looney
Editor-in-Chief
wlooney@advanstar.com
William Looney is the Editor in Chief of Pharmaceutical Executive magazine, a monthly print and weekly on-line publication focused on the “c suite” concerns of senior managers in the biopharmaceutical industry. In addition to editorial content, he is responsible for supporting the magazine through related educational media activities and serving as a thought leader in contacts between the magazine and a wide variety of organizations.
Prior to joining Pharmaceutical Executive in August 2009, Mr. Looney served for 11 years as Senior Director at Pfizer, Inc. where he managed the company’s public policy issue development, positioning and advocacy activities outside the US. In that capacity, he worked closely with the academic and think tank community, coordinated Pfizer CEO relationships with the World Economic Forum, Japan’s Nikkei Management Forum and other policy groups, and chaired committees of key biopharma trade associations, including PhRMA and the IFPMA.
Earlier in his career, he served as an internal communications manager and speech writer at Warner Lambert Company in both the US and in Europe. He also was senior editor for the Economist Intelligent Unit, where he was responsible for consumer issues and management practices in Europe.
He has also been a consultant to the organization for Economic Cooperation and Development [OECD], and is the author of numerous research papers and studies focused on the relationships between product and process innovation and public health.
In March 2011 he was honored by American Business Media with a Neal Award for 'Best Commentary' for his monthly 'From the Editor' columns.
The Future of Fertility: AI, Personalized Medicine, and Ethical Considerations
January 30th 2025Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), discusses how to combat the spread of misinformation on social media, opportunities that social media presents, advancements in fertility technology, and more.
FDA Approves Roche’s Susvimo Refillable Eye Implant for Diabetic Macular Edema
February 4th 2025Roche’s Susvimo, a refillable eye implant for diabetic macular edema, provides continuous delivery of ranibizumab, showing sustained vision improvements with fewer treatments than standard eye injections.
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.